Spectral AI, Inc.

Spectral AI, Inc. (Nasdaq: MDAI) is a medical technology company focused on artificial-intelligence-powered diagnostics for wound assessment, most notably its DeepView system, which uses hyperspectral imaging and machine-learning algorithms to predict burn wound healing outcomes. The company became publicly traded through a de-SPAC merger with Rosecliff Acquisition Corp I, a blank-check vehicle sponsored by Rosecliff Ventures that completed its IPO in 2021. Spectral AI filed this 10-K annual report with the SEC on March 31, 2023, reflecting its status as a post-merger operating company in the healthcare technology sector. Investors and analysts seeking detailed filing history, merger timelines, and SPAC data on Spectral AI and hundreds of similar transactions can sign up for full access at SpacDesk.